To our understanding, however, no study has yet investigated the percentage of MSI-positive tumors according to cancer location and stage, or the influence of CpG island methylation, MSI status and BRAF mutation status in combination on survival by stage and subsite for colon cancer. Here, BRAF is linked to cancer.